Introduction:Basic information about Procaterol hydrochloride CAS 81262-93-3, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Procaterol hydrochloride Basic information
| Product Name: | Procaterol hydrochloride |
| Synonyms: | PROCATEROL HEMIHYDRATE;PROCATEROL HYDROCHLORIDE HEMIHYDRATE;PROCATEROL HCL HEMIHYDRATE;(R*,S*)-(-)-8-Hydroxy-5-(1-hydroxy-2-((1-methylethyl)amino)butyl)-2(1H)-quinolinone hydrochloride;Procaterol hydrochloride;Procaterol hydrochlride hemihydrate;8-hydroxy-5-[(1S,2R)-1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one hydrate dihydrochloride;Hydrochloride hemihydrate |
| CAS: | 81262-93-3 |
| MF: | C16H25ClN2O4 |
| MW: | 344.83 |
| EINECS: | 263-763-0 |
| Product Categories: | Aromatics;API;Other APIs;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals |
| Mol File: | 81262-93-3.mol |
|
Procaterol hydrochloride Chemical Properties
| Melting point | 193-197° (dec) |
| storage temp. | Refrigerator, Under Inert Atmosphere |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| form | Solid |
| color | White to Off-White |
| Stability: | Hygroscopic |
| CAS DataBase Reference | 81262-93-3(CAS DataBase Reference) |
Safety Information
| Toxicity | LD50 of the hydrochloride in male rats (mg/kg): 2600 orally, 80 i.v. (Nakagawa) |
Procaterol hydrochloride Usage And Synthesis
| Uses | Procaterol hydrochloride can be used as short-acting β2-adrenergic receptor agonist used to treat asthma. |
| Uses | Short-acting β2-adrenergic receptor agonist used to treat asthma. |
| Brand name | Pro-Air (Parke-Davis). |
| in vivo | Procaterol hydrochloride hemihydrate (1, 3 or 10 μg/mL, inhaled administration) inhibits histamine-induced airflow obstruction and microvascular leakage in guinea-pig airways with allergic inflammation[2]. Procaterol hydrochloride hemihydrate (0.1 mg/kg, i.p.) completely abolishes both the Mch-induced cough in conscious guinea pigs[3].
| Animal Model: | Allergic inflammatory guinea-pig model[2] | | Dosage: | 1, 3 or 10 μg/mL | | Administration: | Inhaled administration | | Result: | Inhibited histamine-induced airflow obstruction and microvascular leakage. |
|
Procaterol hydrochloride Preparation Products And Raw materials